Skip to main content

Table 1 Echocardiographic assessment of cardiac structure and function

From: The effect of long-term amiodarone administration on myocardial fibrosis and evolution of left ventricular remodeling in a porcine model of ischemic cardiomyopathy

Echocardiographic parameters

Group

Mean ± SD

p value

LVEDD (time 0)

Amiodarone

36.2 ± 1.6 mm

0.117

Control

38.1 ± 1.8 mm

LVESD (time 0)

Amiodarone

26.4 ± 3.2 mm

0.973

Control

26.3 ± 2.0 mm

LVFS (time 0)

Amiodarone

27 ± 8 %

0.363

Control

31 ± 3 %

LVEDD (1st month)

Amiodarone

47.7 ± 4.1 mm

0.591

Control

46.3 ± 2.4 mm

LVESD (1st month)

Amiodarone

36.3 ± 2.5 mm

0.163

Control

31.4 ± 5.7 mm

LVFS (1st month)

Amiodarone

23 ± 4 %

0.162

Control

33 ± 11 %

LVEDD (3rd month)

Amiodarone

53.8 ± 4.0 mm

0.029

Control

60.0 ± 2.8 mm

LVESD (3rd month)

Amiodarone

39.7 ± 4.1 mm

0.180

Control

44.9 ± 5.7 mm

LVFS (3rd month)

Amiodarone

26 ± 5 %

0.868

Control

25 ± 10 %

  1. p value in italics indicates statistical significant differences between groups
  2. LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, LVFS left ventricular fractional shortening